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LETTERS TO THE EDITORPEROXISOME PROLIFERATOR
g COACTIVATOR 1 AND
MITOCHONDRIAL FUNCTION
IN HIBERNATING
MYOCARDIUM
To the Editor:
We read with great interest the very
good article by Kelly and colleagues1
showing reduced mitochondrial func-
tion manifested both as downregu-
lated oxygen consumption and as
a modified expression of mitochon-
drial proteome in a swine model of
myocardial hibernation despite a suc-
cessful coronary artery bypass graft-
ing. The hypothesis of the authors is
intriguing, and a depression in mito-
chondrial activity could provide the
key to deciphering cellular survival
in the setting of the chronically ische-
mic myocardium and the appearance
of the apoptosis in the late phase of
myocardial hibernation, as well as
the incomplete recovery after bypass.
One molecular switch that could
explain the modifications in the mito-
chondrial function in the hibernating
myocardium is peroxisome prolifera-
tor–activated receptor g coactivator-1
(PGC-1), reduction of which has al-
ready been demonstrated by Page and
coworkers2 in the setting of experimen-
tally induced chronically hibernating
myocardium. The reduced activity of
PGC-1 in chronically ischemic myo-
cardium through the reduced mito-
chondrial biogenesis and the reduced
synthesis of the proteins of the electron
transport chain could be the root of the
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954 The Journal of Thoracic and Cthe induction of apoptosis. In a recent
article, Adhihetty and colleagues3
showed that in a model of PGC-1
knockout mice the lack of PGC-1 re-
sulted in muscle in a reduced cellular
mitochondrial content and respiratory
function, in alteredmitochondrial com-
position, and in the increased release of
proapoptotic cytochromeC in response
to exogenous hydrogen peroxide. If the
results demonstrated in skeletal muscle
also proves valid for the myocardial
muscle, many of the experimental re-
sults of Kelly and colleagues1 and the
various steps in the evolution of chron-
ically ischemic myocardium might be
explained on such a basis.
The role of PGC-1 and of mito-
chondrial biogenesis in myocardial
hibernation is yet incompletely
known. In our opinion, this role
should be further studied and clarified.
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We appreciate the constructive
comments of Drs Siracusano and Gir-
asole. We agree that the depressed mi-
tochondrial activity of complexVin theardiovascular Surgery c October 2011electron transport chainmight be a criti-
cal factor in the delayed functional re-
covery after revascularization of the
hibernating myocardium. Whether this
is the cause or effect of the persistent
abnormalities in maximal oxygen con-
sumption or contraction, however, will
need additional studies to elucidate.
In our recent commentary,1 we ac-
knowledged the importance of the ob-
servation that adenosine triphosphatase
expression was reduced in hibernating
myocardium, as elegantly shown by
Page and colleagues.2 We considered
that the causeof thisdecreasewasapro-
gram induced by increased reactive
oxygen species to offset subsequent
oxidant damage. It is conceivable that
a program to promote cardiomyocyte
survival downregulates critical proteins
in the mitochondria that contribute to
reactive oxygen species formation,
and this might result in either an ineffi-
ciency or an inability to maximally
drive electron transport during high
work states. Our findings support this
hypothesis. Determining the possible
disruption of a molecular switch, such
as peroxisome proliferator g coactiva-
tor 1a and mitochondrial biogenesis,3,4
clearly warrants further scientific study
in our revascularized hibernating
myocardial swine model.
In summary,webelieve that thephys-
iologic status of the mitochondria plays
a critical role in the cardiomyocyte’s ca-
pacity to restore maximal myocardial
oxygen consumption and contractility
within hibernating myocardium after
revascularization. By understanding
the regulation of mitochondrial re-
sponses after revascularization, we
hope to identify therapeutic measures
that can ameliorate persistent heart
failure after optimal coronary artery
bypass grafting.
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